Compound 2315
Identifiers
- Canonical SMILES:
NCC(=O)Nc1ccc(N)cc1
- IUPAC name:
2-amino-N-(4-aminophenyl)acetamide
- InChi:
InChI=1S/C8H11N3O/c9-5-8(12)11-7-3-1-6(10)2-4-7/h1-4H,5,9-10H2,(H,11,12)
- InChiKey:
DKCWGVIARWBMDV-UHFFFAOYSA-N
External links
![]() 21263335 |
D3H |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
4 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BAZ2-like PHD / H3 | 4.00 | prostate cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 165.09 g/mol | |||
HBA | 4 | |||
HBD | 5 | |||
HBA + HBD | 9 | |||
AlogP | -0.54 | |||
TPSA | 82.76 | |||
RB | 2 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 4 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1021/acschembio.7b01093 | Fr23 | BAZ2A Q9UIF9 |
H31 P68431 |
Biochemical assay | NMR chemical-shift perturbation BAZ2A PHD | pKd (dissociation constant, -log10) | 2.15 | |
10.1021/acschembio.7b01093 | Fr23 | BAZ2A Q9UIF9 |
H31 P68431 |
Biochemical assay | NMR chemical-shift perturbation BAZ2B PHD | pKd (dissociation constant, -log10) | 2.01 | |
10.1021/acschembio.7b01093 | Fr23 | BAZ2A Q9UIF9 |
H31 P68431 |
Biochemical assay | AlphaLISA BAZ2A PHD | pIC50 (half maximal inhibitory concentration, -log10) | 4.00 | |
10.1021/acschembio.7b01093 | Fr23 | BAZ2A Q9UIF9 |
H31 P68431 |
Biochemical assay | AlphaLISA BAZ2B PHD | pIC50 (half maximal inhibitory concentration, -log10) | 3.70 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6591 | Acetaminophen | DB00316 | |
0.6296 | Tocainide | DB01056 | |
0.6182 | Lidocaine | DB00281 | |
0.5854 | 4-(Isopropylamino)diphenylamine | DB14195 | |
0.5484 | Prilocaine | DB00750 | |
0.5472 | Phenacetin | DB03783 | |
0.5472 | Diloxanide | DB08792 | |
0.5273 | Acedoben | DB04500 | |
0.5238 | N-Allylaniline | DB02870 | |
0.5231 | N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE | DB08348 | |
0.5111 | 1,3-diphenylurea | DB07496 | |
0.5085 | N-acetylsulfanilyl chloride | DB12337 | |
0.5075 | N-[4-(benzyloxy)phenyl]glycinamide | DB07099 | |
0.5075 | Diampromide | DB01502 | |
0.5000 | [[4-(Aminomethyl)Phenyl]Amino]Oxo-Acetic Acid, | DB02420 |